Credit Suisse Ag Invitae Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$0.42 - $0.72 $221,882 - $380,369	528,291 Added 127.56%	942,426 $593,000
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $10,509 - $26,799	17,516 Added 4.42%	414,135 $248,000
Q2 2023 Aug 11, 2023	SELL	$1.05 - $1.63 $1.12 Million - $1.74 Million	-1,067,165 Reduced 72.9%	396,619 $448,000
Q1 2023 May 10, 2023	BUY	$1.2 - $2.73 $629,002 - $1.43 Million	524,169 Added 55.79%	1,463,784 $1.98 Million
Q4 2022 Feb 13, 2023	BUY	$1.71 - $3.61 $81,322 - $171,680	47,557 Added 5.33%	939,615 $1.75 Million
Q3 2022 Nov 10, 2022	SELL	$1.9 - $8.63 $376,108 - $1.71 Million	-197,952 Reduced 18.16%	892,058 $2.19 Million
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $9,210 - $38,959	-4,324 Reduced 0.4%	1,090,010 $2.66 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $3.66 Million - $9.08 Million	582,299 Added 113.72%	1,094,334 $8.72 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $3.46 Million - $6.76 Million	235,664 Added 85.27%	512,035 $7.82 Million
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $13.8 Million - $19.1 Million	-567,169 Reduced 67.24%	276,371 $7.86 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $5.05 Million - $7.82 Million	193,507 Added 29.77%	843,540 $28.7 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $10.2 Million - $17.6 Million	309,806 Added 91.06%	650,033 $24.8 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $5.92 Million - $8.7 Million	151,512 Added 80.29%	340,227 $14.2 Million
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $2.28 Million - $3.59 Million	-80,323 Reduced 29.86%	188,715 $8.18 Million
Q2 2020 Aug 12, 2020	SELL	$11.71 - $30.29 $208,238 - $538,647	-17,783 Reduced 6.2%	269,038 $8.15 Million
Q1 2020 May 13, 2020	SELL	$7.64 - $27.5 $68,844 - $247,802	-9,011 Reduced 3.05%	286,821 $3.92 Million
Q4 2019 Feb 12, 2020	BUY	$15.02 - $20.57 $2.85 Million - $3.91 Million	189,966 Added 179.44%	295,832 $4.77 Million
Q3 2019 Nov 12, 2019	SELL	$18.85 - $27.5 $866,986 - $1.26 Million	-45,994 Reduced 30.29%	105,866 $2.04 Million
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $1.12 Million - $1.7 Million	64,622 Added 74.08%	151,860 $3.57 Million
Q1 2019 May 14, 2019	BUY	$10.65 - $25.75 $646,178 - $1.56 Million	60,674 Added 228.41%	87,238 $2.04 Million
Q4 2018 Feb 13, 2019	SELL	$9.26 - $16.38 $167,680 - $296,609	-18,108 Reduced 40.54%	26,564 $293,000
Q3 2018 Nov 13, 2018	BUY	$7.54 - $18.31 $14,680 - $35,649	1,947 Added 4.56%	44,672 $748,000
Q2 2018 Aug 14, 2018	BUY	$4.87 - $8.42 $45,066 - $77,918	9,254 Added 27.65%	42,725 $314,000
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $17,052 - $36,541	3,636 Added 12.19%	33,471 $157,000
Q4 2017 Feb 14, 2018	BUY	$7.86 - $9.99 $3,977 - $5,054	506 Added 1.73%	29,835 $271,000
Q3 2017 Nov 14, 2017	BUY	$8.89 - $10.4 $150,969 - $176,612	16,982 Added 137.54%	29,329 $275,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,347	12,347 $118,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account